David Cordani sold $59M of CI
Chairman & CEO at Cigna Group. 201,878 shares at an average of $292.82, traded May 12, 2026, filed May 14, 2026.
Score components
- +25RoleCEO
- +25Trade size$59.1M at market
- +20Share of holdings soldSold 85% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +1.6%, 3m -5.2%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001739940-26-000044, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 12, 2026 | MOption exercise Common Stock, $.01 Par Value10b5-1 | +103,595 | $149.14 | $15M | 150,696 | May 14, 2026 |
| May 12, 2026 | MOption exercise Common Stock, $.01 Par Value10b5-1 | +85,519 | $197.35 | $17M | 236,215 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -3,903 | $286.83 | $1.1M | 232,312 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -14,292 | $287.96 | $4.1M | 218,020 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -13,839 | $288.85 | $4.0M | 204,181 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -41,099 | $290.00 | $12M | 163,082 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -13,732 | $291.01 | $4.0M | 149,350 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -12,315 | $291.95 | $3.6M | 137,035 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -7,861 | $292.88 | $2.3M | 129,174 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -2,142 | $293.92 | $630k | 127,032 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -38,487 | $294.98 | $11M | 88,545 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -34,641 | $295.98 | $10M | 53,904 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -2,017 | $296.84 | $599k | 51,887 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -15,319 | $298.24 | $4.6M | 36,568 | May 14, 2026 |
| May 12, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -2,231 | $298.53 | $666k | 34,337 | May 14, 2026 |
| May 13, 2026 | MOption exercise Common Stock, $.01 Par Value10b5-1 | +15,458 | $149.14 | $2.3M | 49,795 | May 14, 2026 |
| May 13, 2026 | MOption exercise Common Stock, $.01 Par Value10b5-1 | +7,971 | $197.35 | $1.6M | 57,766 | May 14, 2026 |
| May 12, 2026 | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -103,595 | $0.00 | $0 | 15,458 | May 14, 2026 |
| May 13, 2026 | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -15,458 | $0.00 | $0 | 0 | May 14, 2026 |
| May 12, 2026 | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -85,519 | $0.00 | $0 | 7,971 | May 14, 2026 |
| May 13, 2026 | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -7,971 | $0.00 | $0 | 0 | May 14, 2026 |
Related signals
Other insiders at Cigna Group and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | Cigna Group | Everett Neville See Remarks | $175k 617 shares | -11% | |
| 16Weak | Cigna Group | Nicole S Jones See Remarks | $749k 2,677 shares | -9% | |
| 15Weak | Cigna Group | Nicole S Jones See Remarks | $5.4M 19,436 shares | -42% | |
| 23Weak | CIsell Cigna Group | Jamie G Kates Chief Accounting Officer | $268k 899 shares | -28% | |
| 23Weak | Cigna Group | Nicole S Jones See Remarks | $667k 2,307 shares | -7% | |
| 26Weak | Cigna Group | Everett Neville See Remarks | $497k 1,719 shares | -23% | |
| 64Notable | CIbuy Cigna Group | David Cordani Chairman & CEO | $1000k 4,134 shares | +3% | |
| 5Weak | Cigna Group | Brian C Evanko See Remarks | $1.6M 5,368 shares | -9% | |
| 25Weak | Cigna Group | Nicole S Jones See Remarks | $8.6M 28,526 shares | -53% | |
| 26Weak | Cigna Group | Elder Granger director | $737k 2,376 shares | -30% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.